Bryan C Hanson

CIK 1524349 · Chief Executive Officer · last filed 2026-09-03

Bryan C Hanson is a Chief Executive Officer who has filed 92 SEC Form 4 insider transactions across 6 companies since 2011. The most recent filing, for SOLV, was dated Sep 3, 2026. Across all open-market trades the lifetime net is −$17.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $34.4M across reported positions. 28 SEC filings were submitted jointly with ZIMMER BIOMET HOLDINGS, INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$34.36M

Companies

6

Total Filings

92

Lifetime Open-Market Net

-$16.96M

Filer Profile

Reported Address
1750 YANKEE DOODLE ROAD
EAGAN, MN 55121
Related Filers
ZIMMER BIOMET HOLDINGS, INC. — 28 joint filings, latest 2023-11-30
Medtronic plc — 22 joint filings, latest 2017-12-18
Solventum Corp — 8 joint filings, latest 2026-05-15
Walgreens Boots Alliance, Inc. — 4 joint filings, latest 2025-08-15
CO 3M — 2 joint filings, latest 2023-09-06
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SOLV Chief Executive Officer 185,515 $87.45 $16.22M $0 8 2026-09-03
Walgreens Boots Alliance, Inc. (WBA) Delisted Director 47,655 $11.98 $570.9K $0 3 2025-08-15
MMM Group Pres & CEO Health Care $164.97 $0 1 2023-09-06
ZBH President and CEO 107,549 $93.49 $10.05M $3.41M 24 2023-03-08
MDT EVP, President, MITG 88,818 $90.96 $8.08M -$9.97M 21 2017-12-18
Covidien plc (COV) Delisted Senior Vice President 64,175 -$10.41M 31 2014-12-04

Recent Filings

92 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-09-03 SOLV Mixed +40,793 -$2.41M EDGAR
2026-05-15 SOLV Mixed +20,812 -$1.00M EDGAR
2026-03-09 SOLV Mixed +21,512 -$721.5K EDGAR
2025-09-02 SOLV Mixed +40,793 -$1.93M EDGAR
2025-08-15 Walgreens Boots Alliance, Inc. (WBA) Delisted Grant (A) +16,820 $0 EDGAR
2025-05-15 SOLV Mixed +20,812 -$992.7K EDGAR
2025-03-10 SOLV Grant (A) $0 EDGAR
2024-11-05 Walgreens Boots Alliance, Inc. (WBA) Delisted Grant (A) +21,141 $0 EDGAR
2024-09-04 SOLV Mixed +40,793 -$1.70M EDGAR
2024-05-15 SOLV Grant (A) $0 EDGAR
Showing 110 of 92
Page 1 of 10
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.